FineMedix Co

FineMedix Co FCF per Share

The Free Cash Flow per Share of FineMedix Co (387570.KQ) as of Nov 2, 2026 is -642.14 KRW. In the previous year, Free Cash Flow per Share was -78.22 KRW — a change of 720.93% (lower).

FCF per Share

-642.14KRW

YoY

720.93%

Last updated:

Free Cash Flow per Share of FineMedix Co is 2025 -642.14 KRW. Free Cash Flow per Share of FineMedix Co was 2024 -78.22 KRW. It decreases by 720.93% lower compared to the previous year.

The FineMedix Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2022
-392.15 KRW
Jan 1, 2023
191.85 KRW
Jan 1, 2024
-78.22 KRW
Jan 1, 2025
-642.14 KRW
The FineMedix Co FCF per Share history
YEARFCF per ShareYoY
-642.14KRW+720.93%
-78.22KRW-140.77%
191.85KRW-148.92%
-392.15KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

FineMedix Co Stock analysis

What does FineMedix Co do? FineMedix Co Ltd generates revenue through the manufacturing and sales of microinvasive medical devices, including therapeutic and diagnostic endoscopes. The company also offers endoscopic surgery devices such as knives, injectors, baskets, endoscopic clips, and snares for endoscopic submucosal dissection and endoscopic mucosal resection. These products are sold to healthcare providers and medical facilities specializing in minimally invasive procedures. The company's primary focus on endoscopic devices positions it within the medical devices manufacturing sector, targeting hospitals and clinics that require advanced tools for minimally invasive surgeries. FineMedix Co Ltd's product portfolio supports both diagnostic and therapeutic applications in endoscopic procedures, catering to the growing demand for less invasive surgical techniques. As a Korea-based firm, FineMedix Co Ltd serves the domestic market with its specialized medical equipment. The company's offerings are designed to meet the needs of medical professionals performing endoscopic surgeries, ensuring precision and efficiency in procedures such as ESD and EMR. FineMedix Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about FineMedix Co stock

Free Cash Flow per Share of FineMedix Co is -642.14 KRW in 2025.

Free Cash Flow per Share of FineMedix Co changed from -78.22 KRW to -642.14 KRW, representing a 720.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share FineMedix Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — FineMedix Co

All Key Metrics — FineMedix Co